(Press-News.org) Mass General Brigham’s evaluation of low-field MRI performance lays potential groundwork for this technology to be a lower-cost, accessible option for breast imaging
Researchers at Mass General Brigham have demonstrated the technical feasibility of using ultra-low field (ULF) magnetic resonance imaging (MRI) for breast imaging. With further refinement and evaluation, the technology could offer an alternative to existing breast cancer screening methods and may reduce barriers to screening. Results are published in Scientific Reports.
“These results are a very encouraging proof of principle, though larger studies are needed to establish diagnostic performance,” said project principal investigator and co-senior author Matthew Rosen, PhD, an associate professor of Radiology and director of the Low Field MRI laboratory in the Athinoula A. Martinos Center for Biomedical Imaging in the Mass General Brigham Department of Radiology. “They motivate our continued pursuit of safe, comfortable, lower-cost screening approaches that can expand access for patients.”
Current U.S. guidelines recommend screening mammography for women aged 40 to 74 years. Unlike mammography, ULF MRI doesn’t require breast compression, which many patients find uncomfortable. Another benefit of ULF MRI is that it doesn’t use ionizing radiation.
While higher risk patients may receive MRI screening for breast cancer, standard MRI machines are not used in routine breast cancer screening because they are expensive and not widely available. ULF MRI systems cost less than 5% of the price of standard MRI systems and have lower long-term operating costs.
In this study, ULF MRI scans were performed on 14 participants, including 11 women with no history of breast cancer, two women with a prior breast cancer diagnosis, and one woman with a benign mass.
When interpreting the ULF MRI scans, three radiologists could reliably identify essential breast features and distinguish fibroglandular tissue from adipose tissue. The authors note that discrepancies were likely related to the novelty of ULF MRI and may be reduced with additional training and experience.
“This early evidence suggests that ULF MRI can detect essential breast features and some abnormalities without radiation or injected contrast,” said co-first author Neha Koonjoo, PhD, an investigator at the Martinos Center. “These findings point to the potential for ULF MRI as an option that could complement existing screening tools in the future.”
“Even at very low magnetic field, the radiology team was able to make observations about the breast,” said co-principal investigator and co-senior author Kathryn E. Keenan, PhD, from the US National Institute of Standards and Technology. “We attempted this study in hopes that the breast features would be visible, but you don’t always have success. We’re very motivated by this study to continue our work on ultra-low-field MRI for breast screening.”
The researchers note that further study is needed to determine the diagnostic accuracy of ULF MRI for breast cancer screening, including studies in larger cohorts that include patients with benign and malignant lesions. They also emphasize that further refinements in ULF MRI technology are needed to meet clinical resolution standards for breast cancer screening.
“These results will guide the next engineering steps to improve image quality and enable a more comfortable exam and help bring screening to more settings and more patients,” said co-first author Sheng Shen, PhD, of the Martinos Center for Biomedical Imaging.
Authorship: In addition to Koonjoo and Rosen, Mass General Brigham authors include Sheng Shen, Friderike K. Longarino, Leslie R. Lamb, Juan C. Villa Camacho, Torben P.P. Hornung, Susu Yan, Thomas R. Bortfeld, and Mansi A. Saksena. Additional authors include Stephen E. Ogier and project co-principal investigator Kathryn E. Keenan at the US National Institute of Standards and Technology.
Disclosures: Rosen is a founder and equity holder of Hyperfine, Inc. Rosen is a consultant and equity holder in DeepSpin GmbH.
Funding: Funding provided by National Institutes of Health grant 1R21CA267315, Kiyomi and Ed Baird MGH Research Scholar award, German-American Fulbright Commission, National Institute of Standards and Technology, and NIST-PREP 70NANB18H006 from U.S. Department of Commerce.
Paper cited: Shen S, Koonjoo N, et al. “Breast imaging with ultra-low field MRI” Scientific Reports DOI: 10.1038/s41598-026-37130-9
###
About Mass General Brigham
Mass General Brigham is an integrated academic health care system, uniting great minds to solve the hardest problems in medicine for our communities and the world. Mass General Brigham connects a full continuum of care across a system of academic medical centers, community and specialty hospitals, a health insurance plan, physician networks, community health centers, home care, and long-term care services. Mass General Brigham is a nonprofit organization committed to patient care, research, teaching, and service to the community. In addition, Mass General Brigham is one of the nation’s leading biomedical research organizations with several Harvard Medical School teaching hospitals. For more information, please visit massgeneralbrigham.org.
END
In 2024, researchers in the Laboratory of Nanoscience for Energy Technology (LNET) in EPFL’s School of Engineering reported a platform for studying the hydrovoltaic (HV) effect – a phenomenon that allows electricity to be harvested when fluid is passed over the charged surface of a nanodevice. Their platform consisted of a hexagonal network of silicon nanopillars, the space between which created channels for evaporating fluid samples.
Now the LNET team, led by Giulia Tagliabue, has developed this platform into a hydrovoltaic system with a power output that matches or exceeds similar technologies – with a major advantage. Instead of relying on heat and light to simply ...
In the realm of entomology, few creatures command as much fascination as the mantis. Throughout history, these striking insects have been deeply woven into local myths and legends, sometimes respected as mystical soothsayers that can guide lost travelers home, and other times feared as little devils.
Today they remain captivating animals, serving as excellent bioindicators of biodiversity, and helping us identify rich and diverse ecosystems when present as native species.
However, a new study published in the open-access Journal of Orthoptera Research reports that two mantis species identified ...
The brain does not only communicate through fast electrical impulses; it also relies on slower, more diffuse chemical signals that modulate our emotional and social states over time. A study led by the Institute for Neurosciences (IN), a joint center of the Spanish National Research Council (CSIC) and the Miguel Hernández University of Elche (UMH), has identified a key molecular mechanism that regulates the release of oxytocin within the brain. Published in the journal Communications Biology, the work sheds light on how this hormone maintains a “social tone” and how its release contributes to the quality of social interactions.
Oxytocin is a hormone widely recognized ...
Public and patient engagement is becoming an established part of academic research, and funders increasingly require that citizens and patients are seen as research partners rather than merely as research subjects. Yet many researchers question what this means in everyday research practice.
An interview-based study conducted at the University of Eastern Finland examined this question from the researchers’ perspective. Researchers from two Finnish universities described their experiences of, and expectations of, public and patient involvement.
The findings focus on power relations between researchers and patients as something that ...
Scientists at Nagoya University in Japan have found two gut bacteria working together that contribute to chronic constipation. The duo, Akkermansia muciniphila and Bacteroides thetaiotaomicron, destroy the intestinal mucus coating essential for keeping the colon lubricated and feces hydrated. Their excess degradation leaves patients with dry, immobile stool. This discovery, published in Gut Microbes, finally explains why standard treatments often fail for millions of people with chronic constipation.
Notably, the study shows that Parkinson's disease patients, who suffer from constipation decades before developing tremors, ...
□ A research team led by Professor Su-Il In of the Department of Energy Science and Engineering at DGIST (President Kunwoo Lee) has uncovered the principle that the products and reaction pathways of carbon dioxide (CO₂) conversion to fuel via solar energy depend on the design of atomic-level interactions in the catalyst.
□ The technology of converting CO₂, a major greenhouse gas, into useful fuels or chemical feedstocks is a key challenge for achieving a carbon-neutral society. In particular, “artificial photosynthesis” technology, which utilizes solar energy to turn greenhouse gases into resources, is attracting attention. However, there ...
A new multinational study from the INTERCOVID Consortium, including Ann & Robert H. Lurie Children’s Hospital of Chicago, has found that COVID-19 vaccination during pregnancy, particularly when combined with a booster dose, significantly reduces the risk of preeclampsia, a serious and potentially life-threatening pregnancy complication. The findings offer unprecedented insight into preeclampsia prevention, independent of the direct effects of COVID-19 infection.
The study, published in eClinicalMedicine, titled COVID-19 Vaccination Status During ...
Menopausal hormone therapy (commonly known as hormone replacement therapy or HRT) is not associated with an increased risk of death, finds a Danish study of over 800,000 women published by The BMJ today.
The findings support current guidelines that recommend hormone therapy for women who have recently begun menopause who have moderate to severe symptoms and no contraindications, say the researchers.
Menopausal hormone therapy can help relieve menopausal symptoms such as hot flashes, sleep disturbance, mood swings, and depression. But its use has steadily declined during the last two decades, mainly due to safety concerns, and real world evidence ...
Four fifths of England’s integrated care boards (ICBs) - responsible for planning health services for their local population - would need to at least double their number of general practitioners to meet staffing standards considered safe for patients, finds an analysis of NHS workforce data published by The BMJ today.
The British Medical Association (BMA) says that, by 2040, England should have one full time equivalent (FTE) GP for every 1,000 patients, to ensure manageable workloads and patient safety.
But new data released last month shows ...
Booster vaccines reduced the risk of COVID‑19–related hospitalisation and death, according to a new study of over 3 million adults who had the autumn 2022 vaccine in England. The research led by the universities of Bristol and Oxford, provides further evidence of the effectiveness of booster vaccination against COVID-19.
The study, published in Vaccine today [18 February], also found that this effectiveness was similar for Moderna (BA.1 mRNA-1273) and Pfizer-BioNTech (BA.1 BNT162b2) booster vaccines, but protection declined over time.
Previous work has shown the initial COVID-19 vaccination was effective in reducing the risk ...
